arrow
M

Miloš Pešek

Charles University Prague
H指数:23
被引数:2,981

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data

PET/CT分期的遗漏与III期非小细胞肺癌的生存率降低有关: 来自卢卡斯项目真实世界数据的见解

2024-07-010
OAAI
Progression-free survival with first line treatment as prognostic factor of treatment success in subsequent lines in lung adenocarcinoma patients - who's the,good responder?
2021-11-250
PRE
Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment - prospective data from the Czech TULUNG registry
2020-10-280
PRE
Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from the Czech Republic
2018-11-190
PRE
Comparison of NSCLC patient groups with activated EGFR mutations treated with three different tyrosine-kinase inhibitors (TKI): Real-life data from the Czech Republic
2017-12-060
PRE